Need Help?

Clinical Utility of BRCA Research by Inocras, CMC and SMC (CUBRICS)

This dataset consists of whole-genome sequences from 1,364 Korean breast cancers, with transcriptome data available for most cases

Request Access

DUO:0000026
version: 2021-02-23

user specific restriction

This data use modifier indicates that use is limited to use by approved users.

DUO:0000028
version: 2021-02-23

institution specific restriction

This data use modifier indicates that use is limited to use within an approved institution.

DUO:0000042
version: 2021-02-23

general research use

This data use permission indicates that use is allowed for general research use for any research purpose.

These terms and conditions govern access to the managed access datasets (details of which are set out in Appendix I) provided by Graduate School of Medical Science and Engineering in Korea Advanced Institute of Science and Technology (KAIST-GSMSE) to which the User Institution has requested access. The User Institution agrees to be bound by these terms and conditions.

These terms and conditions govern access to the managed access datasets (details of which are set out in Appendix I) provided by Graduate School of Medical Science and Engineering in Korea Advanced Institute of Science and Technology (KAIST-GSMSE) to which the User Institution has requested access. The User Institution agrees to be bound by these terms and conditions. Definitions Authorized Personnel: The individuals at the User Institution to whom KAIST-GSMSE grants access to the Data. This includes the User, the individuals listed in Appendix II and any other individuals for whom the User Institution subsequently requests access to the Data. Details of the initial Authorized Personnel are set out in Appendix II. Data: The managed access dataset(s) to which the User Institution has requested access. Data Producers: KAIST-GSMSE and the collaborators listed in Appendix I responsible for the development, organization, and oversight of these Data. External Collaborator: A collaborator of the User, working for an institution other than the User Institution. Project: The project for which the User Institution has requested access to these Data. A description of the Project is set out in Appendix II. Publications: Includes, without limitation, articles published in print journals, electronic journals, reviews, books, posters and other written and verbal presentations of research. Research Participant: An individual whose data form part of these Data. Research Purposes: Shall mean research that is seeking to advance the understanding of genetics and genomics, including the treatment of disorders, and work on statistical methods that may be applied to such research. User: The principal investigator for the Project. User Institution(s): The Institution that has requested access to the Data. 1. The User Institution agrees to only use these Data for the purpose of the Project (described in Appendix II) and only for Research Purposes. The User Institution further agrees that it will only use these Data for Research Purposes which are within the limitations (if any) set out in Appendix I. 2. The User Institution agrees to preserve, at all times, the confidentiality of these Data. In particular, it undertakes not to use, or attempt to use these Data to compromise or otherwise infringe the confidentiality of information on Research Participants. Without prejudice to the generality of the foregoing, the User Institution agrees to use at least the measures set out in Appendix I to protect these Data. 3. The User Institution agrees to protect the confidentiality of Research Participants in any research papers or publications that they prepare by taking all reasonable care to limit the possibility of identification. 4. The User Institution agrees not to link or combine these Data to other information or archived data available in a way that could re-identify the Research Participants, even if access to that data has been formally granted to the User Institution or is freely available without restriction. 5. The User Institution agrees only to transfer or disclose these Data, in whole or part, to the Authorized Personnel. Should the User Institution wish to share these Data with an External Collaborator, the External Collaborator must complete a separate application for access to these Data. 6. The User Institution agrees that the Data Producers, and all other parties involved in the creation, funding or protection of these Data: a) make no warranty or representation, express or implied as to the accuracy, quality or comprehensiveness of these Data; b) exclude to the fullest extent permitted by law all liability for actions, claims, proceedings, demands, losses (including but not limited to loss of profit), costs, awards damages and payments made by the Recipient that may arise (whether directly or indirectly) in any way whatsoever from the Recipient’s use of these Data or from the unavailability of, or break in access to, these Data for whatever reason and; c) bear no responsibility for the further analysis or interpretation of these Data. 7. The User Institution agrees to follow the Toronto Statement (http://www.nature.com/nature/journal/v461/n7261/full/461168a.html). This includes but is not limited to recognizing the contribution of the Data Producers and including a proper acknowledgement in all reports or publications resulting from the use of these Data. 8. The User Institution agrees to follow the Publication Policy in Appendix III. 9. The User Institution agrees not to make intellectual property claims on these Data and not to use intellectual property protection in ways that would prevent or block access to, or use of, any element of these Data, or conclusion drawn directly from these Data. 10. The User Institution can elect to perform further research that would add intellectual and resource capital to these data and decide to obtain intellectual property rights on these downstream discoveries. In this case, the User Institution agrees to implement licensing policies that will not obstruct further research and to follow the U.S. National Institutes of Health Best Practices for the Licensing of Genomic Inventions (2005) (https://www.icgc.org/files/daco/NIH_BestPracticesLicensingGenomicInventions_2005_en.pdf ) in conformity with the Organization for Economic Co-operation and Development Guidelines for the Licensing of the Genetic Inventions (2006) (http://www.oecd.org/science/biotech/36198812.pdf ). 11. The User Institution agrees to destroy/discard the Data held, once it is no longer used for the Project, unless obliged to retain the data for archival purposes in conformity with audit or legal requirements. 12. The User Institution will notify KAIST-GSMSE within 30 days of any changes or departures of Authorized Personnel. 13. The User Institution will notify KAIST-GSMSE prior to any significant changes to the protocol for the Project. 14. The User Institution will notify KAIST-GSMSE promptly when it becomes aware of a breach of the terms or conditions of this agreement. 15. Either party may terminate this agreement by written notice to the other party. If this agreement terminates for any reason, the User Institution will be required to destroy any Data held, including copies and backup copies. This clause does not prevent the User Institution from retaining these data for archival purpose in conformity with audit or legal requirements. 16. The User Institution accepts that it may be necessary for the Data Producers to alter the terms of this agreement from time to time. As an example, this may include specific provisions relating to the Data required by Data Producers other than KAIST-GSMSE. In the event that changes are required, the Data Producers or their appointed agent will contact the User Institution to inform it of the changes and the User Institution may elect to accept the changes or terminate the agreement. 17. The User Institution agrees to distribute a copy of these terms to the Authorized Personnel. The User Institution will procure that the Authorized Personnel comply with the terms of this agreement. 18. This agreement (and any dispute, controversy, proceedings or claim of whatever nature arising out of this agreement or its formation) shall be construed, interpreted and governed by the laws of Republic of Korea (South Korea) and shall be subject to the exclusive jurisdiction of the South Korean courts.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS50000001062 Whole Genome Sequencing

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Quality Report
Located in
EGAF00008740187 bam 5.7 GB
EGAF00008740188 bam 7.2 GB
EGAF00008740189 bam 7.7 GB
EGAF00008740190 bam 5.9 GB
EGAF00008740191 cram 13.7 GB
EGAF00008740192 cram 13.8 GB
EGAF00008740193 cram 15.2 GB
EGAF00008740194 cram 16.2 GB
EGAF00008740195 cram 16.0 GB
EGAF00008740196 cram 17.2 GB
EGAF00008740197 cram 16.5 GB
EGAF00008740198 cram 18.3 GB
EGAF00008740199 cram 16.2 GB
EGAF00008740200 bam 6.9 GB
EGAF00008740201 bam 7.2 GB
EGAF00008740432 bam 7.4 GB
EGAF00008740551 bam 4.8 GB
EGAF00008740557 cram 15.9 GB
EGAF00008740558 cram 19.0 GB
EGAF00008740594 cram 10.3 GB
EGAF00008740596 cram 14.6 GB
EGAF00008740729 cram 17.0 GB
EGAF00008741044 cram 16.2 GB
EGAF00008741533 bam 5.4 GB
EGAF00008741534 bam 6.4 GB
EGAF00008741535 bam 5.1 GB
EGAF00008741536 cram 6.0 GB
EGAF00008741537 bam 5.5 GB
EGAF00008741538 cram 6.7 GB
EGAF00008741539 bam 5.3 GB
EGAF00008741540 bam 6.9 GB
EGAF00008741541 bam 7.0 GB
EGAF00008741542 bam 4.5 GB
EGAF00008741543 cram 8.7 GB
EGAF00008741544 cram 9.0 GB
EGAF00008741545 bam 5.3 GB
EGAF00008741546 cram 7.7 GB
EGAF00008741547 bam 5.5 GB
EGAF00008741548 cram 13.2 GB
EGAF00008741549 cram 8.2 GB
EGAF00008741550 cram 7.5 GB
EGAF00008741551 cram 13.1 GB
EGAF00008741552 cram 7.5 GB
EGAF00008741553 cram 10.6 GB
EGAF00008741554 cram 6.2 GB
EGAF00008741555 bam 4.6 GB
EGAF00008741556 cram 6.4 GB
EGAF00008741557 cram 15.4 GB
EGAF00008741558 cram 12.1 GB
EGAF00008741559 bam 6.5 GB
EGAF00008741560 cram 8.3 GB
EGAF00008741561 cram 17.3 GB
EGAF00008741562 cram 21.2 GB
EGAF00008741563 cram 21.2 GB
EGAF00008741564 cram 17.4 GB
EGAF00008741565 cram 16.5 GB
EGAF00008741566 cram 14.9 GB
EGAF00008741567 cram 6.1 GB
EGAF00008741568 cram 8.6 GB
EGAF00008741569 cram 12.4 GB
EGAF00008741570 cram 7.9 GB
EGAF00008741571 cram 18.0 GB
EGAF00008741572 cram 12.9 GB
EGAF00008741573 cram 10.5 GB
EGAF00008741574 cram 22.6 GB
EGAF00008741575 cram 15.9 GB
EGAF00008741576 cram 25.0 GB
EGAF00008741577 cram 13.7 GB
EGAF00008741578 bam 4.9 GB
EGAF00008741579 bam 8.8 GB
EGAF00008741580 cram 16.4 GB
EGAF00008741581 cram 11.5 GB
EGAF00008741582 cram 8.3 GB
EGAF00008741583 cram 15.4 GB
EGAF00008741584 cram 5.3 GB
EGAF00008741585 bam 4.2 GB
76 Files (839.9 GB)